You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

COPEGUS

Showing 1 - 25 of 217
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis C Infection Trial in Beijing, Hong Kong (PR4 + LDV/SOF + ASV 4 wk, PR4 + LDV/SOF + SMV 4 wk, PR4 + LDV/SOF +

Recruiting
  • Chronic Hepatitis C Infection
  • PR4 + LDV/SOF + ASV 4 wk
  • +7 more
  • Beijing, Beijing, China
  • +1 more
Aug 27, 2021

Hepatitis C Trial in Bradford, London, Nottingham (Telaprevir, 40 Kd Pegylated interferon alfa 2a, Ribavirin)

Completed
  • Hepatitis C
  • Bradford, United Kingdom
  • +3 more
Jan 4, 2023

Follicular Lymphoma, Mantle Cell Lymphoma Trial in New York (Ribavirin)

Terminated
  • Follicular Lymphoma
  • Mantle Cell Lymphoma
  • New York, New York
    Weill Cornell Medicine
Sep 20, 2021

Hepatitis C Trial in Rotterdam (Peginterferon alfa-2a, Interferon alfa-2a, Ribavirin)

Completed
  • Hepatitis C
  • Peginterferon alfa-2a
  • +2 more
  • Rotterdam, Netherlands
    Erasmus Medical Center
Aug 26, 2021

Hepatitis C, Chronic Trial in Chennai (Sofosbuvir, Pegylated Interferon alfa-2a, Ribavirin)

Completed
Has Results
  • Hepatitis C, Chronic
  • Chennai, Tamil Nadu, India
    YR Gaitonde Centre for AIDS Research and Education
Mar 22, 2021

HIV Infection, Hepatitis C Infection Trial in Puerto Rico, United States (Nitazoxanide (NTZ), Pegylated interferon alfa-2a

Completed
Has Results
  • HIV Infection
  • Hepatitis C Infection
  • Nitazoxanide (NTZ)
  • +2 more
  • Birmingham, Alabama
  • +17 more
Nov 2, 2021

Chronic Hepatitis Trial in Italy (Peginterferon alpha-2a + Ribavirin)

Completed
  • Chronic Hepatitis
  • Peginterferon alpha-2a + Ribavirin
  • Avellino, Italy
  • +34 more
Mar 9, 2022

Hepatitis C Trial in Worldwide (telaprevir, ribavirin, peginterferon alfa-2a)

Completed
Has Results
  • Hepatitis C
  • Birmingham, Alabama
  • +81 more
Mar 3, 2021

Chronic Hepatitis C Virus Infection Trial in New Zealand, United States (telaprevir, VX-222, ribavirin)

Terminated
  • Chronic Hepatitis C Virus Infection
  • La Jolla, California
  • +20 more
Sep 22, 2020

HIV Trial in London (Ribavirin, Raltegravir)

Completed
Has Results
  • HIV Infections
  • London, United Kingdom
    Imperial College Healthcare NHS Trust
Sep 30, 2019

Hepatitis C, HIV Trial in Badalona, Barcelona (Peginterferón alfa-2a (40 KD) (Pegasys®) 180 ug/week, Ribavirin (Copegus®) 1600

Completed
  • Hepatitis C
  • HIV Infections
  • Peginterferón alfa-2a (40 KD) (Pegasys®) 180 ug/week
  • +2 more
  • Badalona, Barcelona, Spain
  • +1 more
Dec 3, 2019

Chronic Hepatitis c, Cirrhosis, Liver, Fibrosis, Liver Trial in United States (Peginterferon alfa-2a + Ribavirin, Peginterferon

Completed
Has Results
  • Chronic Hepatitis c
  • +3 more
  • Peginterferon alfa-2a + Ribavirin
  • Peginterferon alfa-2a
  • Long Beach, California
  • +10 more
Apr 29, 2020

Hepatitis C, Chronic Trial in Israel (peginterferon alfa-2a [Pegasys], ribavirin [Copegus])

Completed
Has Results
  • Hepatitis C, Chronic
  • peginterferon alfa-2a [Pegasys]
  • ribavirin [Copegus]
  • Afula, Israel
  • +25 more
Dec 20, 2017

Liver Disease Trial in New York, Dallas (sofosbuvir/ledipasvir, sofosbuvir, Ribavirin)

Terminated
Has Results
  • Liver Disease
  • New York, New York
  • +2 more
Jan 7, 2019

Hepatitis C Trial in Australia, New Zealand (Sofosbuvir and ribavirin)

Completed
  • Hepatitis C
  • Sofosbuvir and ribavirin
  • Sydney, New South Wales, Australia
  • +4 more
Sep 19, 2018

End-Stage Renal Disease, Hepatitis C Trial in Baltimore (Zepatier, Ribavirin, Sofosbuvir)

Completed
Has Results
  • End-Stage Renal Disease
  • Hepatitis C
  • Baltimore, Maryland
    Johns Hopkins Hospital
Aug 8, 2018

Chronic HCV Infection Trial in Japan (LDV/SOF, RBV)

Completed
Has Results
  • Chronic HCV Infection
  • Ichikawa, Chiba, Japan
  • +18 more
Oct 19, 2018

Hepatitis C Virus Infection Trial (SOF/RBV/PegINFa-2)

Completed
  • Hepatitis C Virus Infection
  • (no location specified)
May 6, 2020

Hepatitis C, Chronic Trial in United States (peginterferon alfa-2a [Pegasys], Copegus)

Completed
Has Results
  • Hepatitis C, Chronic
  • peginterferon alfa-2a [Pegasys]
  • Copegus
  • Birmingham, Alabama
  • +27 more
Feb 28, 2018

Chronic Hepatitis C Trial in Omaha (Peginterferon alpha-2a and ribavirin, Peginterferon alpha-2a , ribavirin and betaine)

Withdrawn
  • Chronic Hepatitis C
  • Peginterferon alpha-2a and ribavirin
  • Peginterferon alpha-2a , ribavirin and betaine
  • Omaha, Nebraska
    Nebraska Medical Center
Mar 8, 2018

Chronic Hepatitis C Infection Trial in Beijing, Hong Kong (SOF+RBV, SOF+DCV, LDV/SOF)

Completed
  • Chronic Hepatitis C Infection
  • Beijing, Beijing, China
  • +1 more
Mar 16, 2018

Hepatitis C Infection Trial in Puerto Rico, United States (Placebo, SCY-635, Pegasys)

Completed
Has Results
  • Hepatitis C Infection
  • Placebo
  • +3 more
  • San Francisco, California
  • +3 more
Jul 18, 2017

Thrombocytopenia Trial in Los Angeles, Fairfax (Avatrombopag, Placebo, Pegylated interferon (PEG-IFN))

Completed
Has Results
  • Thrombocytopenia
  • Los Angeles, California
  • +1 more
Jan 25, 2018

Hepatitis C, Chronic Trial in Israel (COPEGUS, peginterferon alfa-2a [Pegasys])

Completed
Has Results
  • Hepatitis C, Chronic
  • COPEGUS
  • peginterferon alfa-2a [Pegasys]
  • Afula, Israel
  • +19 more
May 5, 2017

Effectiveness of Pegylated Interferon in a Cohort of Hepatitis C

Completed
Has Results
  • Hepatitis C, Chronic
  • Tbilisi, Georgia
  • +2 more
May 5, 2017